1. Gérvas J. [Quaternary prevention in the elderly]. Rev Esp Geriatr Gerontol. 2012;47(6):266-9. doi: 10.1016/j.regg.2012.07.001.
2. NCBI. Quaternary Prevention. Available from: https://www.ncbi.nlm.nih.gov/mesh/?term=quaternary+prevention (accessed Feb 2025).
3. Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629. doi: 10.1183/13993003.00629-2017.
4. Barker A. Bronchiectasis in adults: Maintaining lung health. Available from: https://www-uptodate-com.lo-hsp.a17.csinet.es/contents/bronchiectasis-in-adults-maintaining-lung-health?search=bronquiectasias&source=search_result&selectedTitle=3%7E150&usage_type=default&display_rank=3 (accessed Feb 2025).
5. Nakagawa N, Ito M, Asakura T, Horita N, Obase Y, Mukae H. Efficacy and safety of long-term macrolide therapy for non-cystic fibrosis bronchiectasis: A
systematic review and meta-analysis. Respir Investig. 2024;62(6):1079-1087. doi: 10.1016/j.resinv.2024.09.004.
6. Manterola C, Asenjo-Lobos C, Otzen T. [Hierarchy of evidence: levels of evidence and grades of recommendation from current use]. Rev Chilena Infectol. 2014;31(6):705-18. doi: 10.4067/S0716-10182014000600011.
7. Kelly C, Chalmers JD, Crossingham I, Relph N, Felix LM, Evans DJ, et al. Macrolide antibiotics for bronchiectasis. Cochrane Database Syst Rev. 2018;3(3):CD012406. doi: 10.1002/14651858.CD012406.pub2.
8. Otte JA, Llargués Pou M. Enablers and barriers to a quaternary prevention approach: a qualitative study of field experts. BMJ Open. 2024;14(3):e076836. doi: 10.1136/bmjopen-2023-076836.
9. Norman AH, Tesser CD. Quaternary prevention: a balanced approach to demedicalisation. Br J Gen Pract. 2019;69(678):28-9. doi: 10.3399/bjgp19X700517.